“Since the beginning of the health crisis, the government has been fighting with insurers to get them to help support the French economy (…)
According to the closing announced on December 14, the three healthcare funds have been endowed with a total of 780 million euros. Their priority is to finance the relocation of research laboratories or drug production units, the development of healthcare services, research, innovation, the development of medicines, technologies and devices for healthcare, and disease prevention. (…)”
L’Usine Nouvelle article: https://www.usinenouvelle.com/editorial/fareva-premiere-entreprise-de-sante-financee-par-les-fonds-de-relance-des-assureurs.N1040379
